| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |